ClinicalTrials.Veeva

Menu

Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring

F

Free University of Brussels (ULB)

Status

Completed

Conditions

Surgery

Treatments

Device: Capstesia

Study type

Observational

Funder types

Other

Identifiers

NCT03137901
P2017/224 / B406201731906

Details and patient eligibility

About

This study test the agreement and precision of Pulse Pressure Variation (PPV) and Cardiac Output (CO) obtained by the Android application Capstesia™ against another pulse contour CO monitoring ( EV-1000, Edwards Lefesciences, USA)

Full description

Pulse pressure variation (PPV) remains a good predictor of fluid responsiveness in the OR. However, PPV can be time-consuming to calculate (manual determination), is not always displayed on monitoring screens nor reliable through visual assessment and needs additional devices to be displayed. A new Android application (Captesia) automatically calculates the PPV utilizing a digital photograph of the arterial waveform from the monitor. The application determines the PPV by selecting peaks and troughs of the arterial curve.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients scheduled for major surgery which requires a CO and PPV monitoring as standard of care

Exclusion criteria

  • patients with arrhythmias like atrial fibrillation
  • patients with valvular insufficiency

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems